21 CFR 556.425

§ 556.425 Morantel.

United States · 21 CFR — Food and Drugs · Status: effective

Cite this

Citation: 21 CFR 556.425, § 556.425 Morantel, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87791
Permanent ID: ys:prov:87791@1
SHA-256: cf24ebaad2e270462fcd1ef0d18620713827d644aa03abab97dc258bbcbee562

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Acceptable daily intake (ADI). The ADI for total residue of morantel tartrate is 10 µg/kg of body weight per day. (b) Tolerances. The tolerances for N-methyl-1,3-propanediamine (marker residue) are: (1) Cattle. (i) Liver (target tissue): 0.7 ppm. (ii) Milk: Not required. (2) Goats. (i) Liver (target tissue): 0.7 ppm. (ii) Milk: Not required. (c) Related conditions of use. See §§ 520.1450a, 520.1450b, 520.1450c, and 558.360 of this chapter.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.